Protocol Ledger

NCT04718961 · Phase II · TERMINATED

A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

Interventional Phase II clinical trial protocol NCT04718961 sponsored by Mirum Pharmaceuticals in Gastroenterology, Hepatology, and Renal, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-01-04 Enrollment: 4 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04718961
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)4 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04718961
Protocol FieldVerified Registry Value
NCT IdentifierNCT04718961
Consolidated Lead SponsorMirum Pharmaceuticals
Therapeutic Condition CohortGastroenterology, Hepatology, and Renal
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment4 participants (ACTUAL)
Registered Start Date2021-01-04
WhyStopped ClassificationInsufficient / Slow Accrual

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Gastroenterology, Hepatology, and Renal Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI